[The renin-angiotensin system:implications, pathology, therapeutic possibilities, perspectives].
The renin-angiotensin system is initiate by numerous pathological situations which release the renal ischemia: heart failure, arterial hypertension, renal pathology with or without diabetes mellitus. Therapeutic possibilities in renin-angiotensin system control are offered by angiotensin-converting enzyme inhibitors, angiotensin II type-1 receptors antagonists, angiotensin converting enzyme inhibitors and neutral endopeptidase inhibitors and angiotensin II type 2 receptors agonists.
Ionescu
S D
SD
Facultatea de Medicină Clinica a III-a Medicală Cardiologică I. Enescu, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
Sandru
V
V
Burdujan
A
A
Tovarniţchi
S
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D017706:Lisinopril / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000502:physiology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D017706:Lisinopril